Evaluating Different Medications Used in the Treatment of Polycystic Ovarian Syndrome in Tikrit City Women
Abstract
One of the most common endocrine disorders that impacts reproductive-aged women is Polycystic Ovary Syndrome (PCOS). There are various pharmacological agents used to manage the condition, such as antiandrogens, aromatase inhibitors, metformin, thiazolidinediones, and ovulation-inducing medications. Such medications focus on increasing insulin sensitivity and restoring ovulatory function. The clinical characterizations of polycystic ovary syndrome include hyperandrogenism, menstrual irregularities, and polycystic ovarian morphology. The objective of this research is to estimate the effectiveness of different medications on the signs and symptoms of polycystic ovary syndrome.
Methods: From October to December 2024, a cross-sectional study was performed on 204 women in Iraq aged between 15 and 45 years to assess the therapeutic practices for PCOS. To acquire the relevant data, private gynecological consultations were held, including laboratory measurements and a questionnaire, which were analyzed using Microsoft Excel 2021.
Results: The findings showed that the commonly-prescribed medications are Metformin (35.2%) and Diane 35 (34.8%). Furthermore, menstrual interruptions, hirsutism, and acne were the most commonly-reported symptoms. Hormonal evaluations show that there was heterogeneity between participants, especially regarding the levels of androgen and reproductive hormones. The findings are reflective of typical polycystic ovary syndrome clinical manifestations and the…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 204 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.